Lisa Del Bel Belluz

Imperial College London — United Kingdom

Biochemistry, Genetics and Molecular Biology · Life Sciences

9h-index447citations25works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(7), Cell Adhesion Molecules Research(5), Genetic factors in colorectal cancer(4), Lung Cancer Treatments and Mutations(3), BRCA gene mutations in cancer(3)

Publications25 total

The mutational landscape of the adult healthy parous and nulliparous human breast
Nature Communications·2023· 16 citedOpen Access
Supplementary Figures 1-3 from An EMILIN1-Negative Microenvironment Promotes Tumor Cell Proliferation and Lymph Node Invasion
2023Open Access
Data from An EMILIN1-Negative Microenvironment Promotes Tumor Cell Proliferation and Lymph Node Invasion
2023Open Access
Supplementary Figures 1-3 from An EMILIN1-Negative Microenvironment Promotes Tumor Cell Proliferation and Lymph Node Invasion
2023Open Access
Data from An EMILIN1-Negative Microenvironment Promotes Tumor Cell Proliferation and Lymph Node Invasion
2023Open Access
Abstract PD5-10: Mutational burden of the normal breast during age and pregnancy
Cancer Research·2021
Mutational landscapes of normal breast during age and pregnancy determine cancer risk
2020· 4 citedOpen Access
Abstract P4-04-06: Study of the mutational landscape of normal and pregnant breast to predict pregnancy-associated breast cancer risk
Cancer Research·2019
P077 SMAD7 shows a biphasic expression pattern during progression of ulcerative colitis-associated colorectal cancer
Journal of Crohn s and Colitis·2019Open Access
Correction: Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy
Oncotarget·2018Open Access
Correction: Does molecular profiling of tumors using the Caris molecular intelligence platform improve outcomes for cancer patients?
Oncotarget·2018Open Access
Correction: The benefit of tumor molecular profiling on predicting treatments for colorectal adenocarcinomas
Oncotarget·2018Open Access
Molecular profiling of advanced breast cancer tumors is beneficial in assisting clinical treatment plans
Oncotarget·2018· 6 citedOpen Access
Investigating the benefits of molecular profiling of advanced non-small cell lung cancer tumors to guide treatments
Oncotarget·2018· 2 citedOpen Access
Does molecular profiling of tumors using the Caris molecular intelligence platform improve outcomes for cancer patients?
Oncotarget·2018· 12 citedOpen Access
The benefit of tumor molecular profiling on predicting treatments for colorectal adenocarcinomas
Oncotarget·2018· 3 citedOpen Access
Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy
Oncotarget·2017· 3 citedOpen Access
The Typhoid Toxin Promotes Host Survival and the Establishment of a Persistent Asymptomatic Infection
PLoS Pathogens·2016· 84 citedOpen Access
Local inhibition of elastase reduces EMILIN1 cleavage reactivating lymphatic vessel function in a mouse lymphoedema model
Clinical Science·2016· 26 citedOpen Access
Evolutionarily Conserved Heterogeneous Nuclear Ribonucleoprotein (hnRNP) A/B Proteins Functionally Interact with Human and Drosophila TAR DNA-binding Protein 43 (TDP-43)
Journal of Biological Chemistry·2014· 46 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Biancastella Cereser(13), Justin Stebbing(13), Neha Tabassum(12), Carla Danussi(10), Bruna Wassermann(10), Eliana Pivetta(10), Teresa Maria Elisa Modica(10), Alfonso Colombatti(10), Paola Spessotto(10), Nina Moderau(10), Paul Carter(9), Pramodh Chandrasinghe(9), C. Alifrangis(8), Jonathan Krell(8), Alessandra Petrucco(7), Angela Yiu(3), Sladjana Zagorac(3), Cristian Miere(3), Alicia Rose Jeffries-Jones(3), Thomas J. Herzog(3)